Newsfeeds - Spark Newswire

2 minute read

$5.1 Million Bet On Tabula Rasa HealthCare? 3 Penny Stocks Insiders Are Buying

Today, 6:28 AM

US crude oil futures traded higher by around 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

DSNY

5 minute read

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:28 AM

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

3 minute read

Recap of Monday’s Biotech Catalysts – End of the Day Summary

By Ragothaman Srinivasan

Today, 6:28 AM

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

ABBV

1 minute read

Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO

By Vandana Singh

Today, 6:28 AM

Following its End of Phase 2 Meeting with the FDA, Entera Bio Ltd (NASDAQ:ENTX) has designed the pivotal study for EB613 as…

ENTX

5 minute read

82 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:28 AM

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tuesday.

ACLX

2 minute read

FDA
News

Entera Bio Files Patent Applications For Inventions That Optimize Its Platform Technology For Oral Delivery Of Large Molecule Therapeutics

By Benzinga Newsdesk

Today, 6:28 AM

Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced that it recently filed multiple U.S. patent applications to further strengthen the

ENTX

2 minute read

5 Penny Stocks Insiders Are Buying: Tellurian, Accelerate Diagnostics And More

By Lisa Levin

Today, 6:28 AM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AXDX

3 minute read

News

Entera Bio Publishes Key Study Describing Its Oral Delivery Technology Platform For Biologic Drugs

By Benzinga Newsdesk

Today, 6:28 AM

Entera Bio Ltd. (NASDAQ:ENTX), today announced that researchers at the company and the University of East Anglia in the UK published preclinical in vivo studies which demonstrate the technologies efficiency in the oral

ENTX

1 minute read

Entera Bio’s Formulated Human Parathyroid Hormone Shows Encouraging BMD Data

By Vandana Singh

Today, 6:28 AM

Entera Bio Ltd (NASDAQ:ENTX) has presented the 6-month bone mineral density (BMD) data from its Phase 2 trial of EB613, an…

ENTX

4 minute read

FDA
News

Entera Bio Presents Phase 2 6-Month Bone MIneral Density Data For Oral PTH Formulation At Late Breaker ASBMR Conference Session; Says Linear Dose Responses Seen; Says Pivotal Phase 3 Registration Study Expected To Commence In 2022

By Benzinga Newsdesk

Today, 6:28 AM

Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of orally delivered large molecule therapeutics, presented the 6-month bone mineral density (BMD) data from its completed Phase 2 clinical trial of EB613, an

ENTX